SARS-COV-2 nucleocapsid protein
SARS-COV-2 nucleocapsid protein has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Mar 9, 2023: “SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Central South University and 2 more
- Humans1
What did studies of SARS-COV-2 nucleocapsid protein find?
2Studies of SARS-COV-2 nucleocapsid protein measured 2 outcomes; the most studied are cognitive function (1 study) and cellular senescence (1).
Cognitive function
downin mice1
1 study
Cognitive function
downin mice1
SARS-COV-2 nucleocapsid protein impairs cognitive function in mice.
“SARS-CoV-2 N protein-induced metabolic shifting toward glycolysis initiated a cascade of microglial senescence, which propagated cognitive impairment.”
Animalsin mice
Molecular medicine (Cambridge, Mass.)
Cellular senescence
upin mice1
1 study
Cellular senescence
upin mice1
SARS-COV-2 nucleocapsid protein induces cellular senescence in mice.
“SARS-CoV-2 N protein caused microglial senescence both in vivo and in vitro.”
Animalsin mice
Molecular medicine (Cambridge, Mass.)